SUMMARIZED FINANCIAL INFORMATION (Tables)

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2011

Sep. 30, 2010

Sep. 30, 2011

Sep. 30, 2010

Dec. 31, 2010

Summarized Financial Information [Abstract]

Condensed Consolidating Statement of Operations

Condensed Consolidating Statement of Operations Three Months Ended September 30, 2011
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Net revenues	$    195,552	$ 1,591,099	$    185,257	$      (65,503)	$  1,906,405
Operating costs and expenses:
Cost of services	130,350	920,778	65,446	-	1,116,574
Selling, general and administrative	29,507	332,204	92,314	(7,430)	446,595
Amortization of intangible assets	392	17,654	1,356	-	19,402
Royalty (income) expense	(104,113)	104,113	-	-	-
Other operating (income) expense, net	(382)	455	1,708	-	1,781
Total operating costs and expenses	55,754	1,375,204	160,824	(7,430)	1,584,352
Operating income	139,798	215,895	24,433	(58,073)	322,053
Non-operating (expense) income, net	(43,595)	(53,859)	597	58,073	(38,784)
Income from continuing operations before taxes	96,203	162,036	25,030	-	283,269
Income tax expense	32,178	63,823	5,125	-	101,126
Income from continuing operations	64,025	98,213	19,905	-	182,143
Loss from discontinued operations, net of taxes	-	(250)	-	-	(250)
Equity earnings from subsidiaries	107,823	-	-	(107,823)	-
Net income	171,848	97,963	19,905	(107,823)	181,893
Less: Net income attributable to noncontrolling interests	-	-	10,045	-	10,045
Net income attributable to Quest Diagnostics	$    171,848	$      97,963	$        9,860	$    (107,823)	$     171,848

Condensed Consolidating Statement of Operations Three Months Ended September 30, 2010
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Net revenues	$     209,156	$ 1,540,714	$    186,307	$     (71,522)	$ 1,864,655
Operating costs and expenses:
Cost of services	133,527	894,001	63,937	-	1,091,465
Selling, general and administrative	32,043	307,533	94,515	(7,529)	426,562
Amortization of intangible assets	618	7,597	1,700	-	9,915
Royalty (income) expense	(105,055)	105,055	-	-	-
Other operating expense (income), net.	1,499	73	(1,726)	-	(154)
Total operating costs and expenses	62,632	1,314,259	158,426	(7,529)	1,527,788
Operating income	146,524	226,455	27,881	(63,993)	336,867
Non-operating (expense) income, net	(33,314)	(58,341)	1,813	63,993	(25,849)
Income from continuing operations before taxes	113,210	168,114	29,694	-	311,018
Income tax expense	29,294	66,251	7,357	-	102,902
Income from continuing operations	83,916	101,863	22,337	-	208,116
Loss from discontinued operations, net of taxes	-	(360)	-	-	(360)
Equity earnings from subsidiaries	114,159	-	-	(114,159)	-
Net income	198,075	101,503	22,337	(114,159)	207,756
Less: Net income attributable to noncontrolling interests	-	-	9,681	-	9,681
Net income attributable to Quest Diagnostics	$     198,075	$    101,503	$      12,656	$   (114,159)	$    198,075

Condensed Consolidating Statement of Operations Nine Months Ended September 30, 2011
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Net revenues	$    597,362	$ 4,671,748	$    566,136	$   (204,063)	$ 5,631,183
Operating costs and expenses:
Cost of services	375,283	2,737,849	204,834	-	3,317,966
Selling, general and administrative	103,469	986,510	289,517	(22,254)	1,357,242
Amortization of intangible assets	1,098	41,851	4,894	-	47,843
Royalty (income) expense	(310,887)	310,887	-	-	-
Other operating expense, net.	235,924	826	1,515	-	238,265
Total operating costs and expenses	404,887	4,077,923	500,760	(22,254)	4,961,316
Operating income	192,475	593,825	65,376	(181,809)	669,867
Non-operating (expense) income, net	(127,721)	(164,314)	4,362	181,809	(105,864)
Income from continuing operations before taxes	64,754	429,511	69,738	-	564,003
Income tax expense	68,946	169,566	17,602	-	256,114
Income (loss) from continuing operations	(4,192)	259,945	52,136	-	307,889
Loss from discontinued operations, net of taxes	-	(1,131)	-	-	(1,131)
Equity earnings from subsidiaries	285,322	-	-	(285,322)	-
Net income	281,130	258,814	52,136	(285,322)	306,758
Less: Net income attributable to noncontrolling interests	-	-	25,628	-	25,628
Net income attributable to Quest Diagnostics	$    281,130	$    258,814	$      26,508	$    (285,322)	$     281,130

Condensed Consolidating Statement of Operations Nine Months Ended September 30, 2010
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Net revenues	$    638,796	$ 4,564,026	$     560,016	$   (217,953)	$ 5,544,885
Operating costs and expenses:
Cost of services	385,350	2,660,571	190,888	-	3,236,809
Selling, general and administrative	76,394	934,116	288,619	(22,422)	1,276,707
Amortization of intangible assets	653	22,829	5,062	-	28,544
Royalty (income) expense	(311,863)	311,863	-	-	-
Other operating expense (income), net.	1,178	539	(215)	-	1,502
Total operating costs and expenses	151,712	3,929,918	484,354	(22,422)	4,543,562
Operating income	487,084	634,108	75,662	(195,531)	1,001,323
Non-operating (expense) income, net	(103,847)	(179,726)	4,113	195,531	(83,929)
Income from continuing operations before taxes	383,237	454,382	79,775	-	917,394
Income tax expense	133,356	179,329	21,246	-	333,931
Income from continuing operations	249,881	275,053	58,529	-	583,463
Loss from discontinued operations, net of taxes	-	(678)	-	-	(678)
Equity earnings from subsidiaries	305,257	-	-	(305,257)	-
Net income	555,138	274,375	58,529	(305,257)	582,785
Less: Net income attributable to noncontrolling interests	-	-	27,647	-	27,647
Net income attributable to Quest Diagnostics	$    555,138	$    274,375	$      30,882	$   (305,257)	$    555,138

Condensed Consolidating Balance Sheet

Condensed Consolidating Balance Sheet September 30, 2011
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Assets
Current assets:
Cash and cash equivalents	$      53,183	$      10,914	$      46,728	$                -	$    110,825
Accounts receivable, net	19,090	172,687	744,482	-	936,259
Other current assets	62,436	190,949	96,169	(361)	349,193
Total current assets	134,709	374,550	887,379	(361)	1,396,277
Property, plant and equipment, net	164,278	601,139	40,626	-	806,043
Goodwill and intangible assets, net	155,138	6,246,343	449,318	-	6,850,799
Intercompany (payable) receivable	(394,806)	680,511	(285,705)	-	-
Investment in subsidiaries	7,854,227	-	-	(7,854,227)	-
Other assets	310,661	43,311	50,011	(130,631)	273,352
Total assets	$  8,224,207	$ 7,945,854	$ 1,141,629	$ (7,985,219)	$ 9,326,471
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued expenses..	$    740,094	$    140,012	$      48,417	$          (361)	$    928,162
Short-term borrowings and current portion of long-term debt	743,346	6,944	85,620	-	835,910
Total current liabilities	1,483,440	146,956	134,037	(361)	1,764,072
Long-term debt	3,024,344	18,499	325,004	-	3,367,847
Other liabilities	194,037	537,677	48,505	(130,631)	649,588
Stockholders' equity:
Quest Diagnostics stockholders' equity...	3,522,386	7,242,722	611,505	(7,854,227)	3,522,386
Noncontrolling interests	-	-	22,578	-	22,578
Total stockholders' equity	3,522,386	7,242,722	634,083	(7,854,227)	3,544,964
Total liabilities and stockholders' equity	$ 8,224,207	$   7,945,854	$ 1,141,629	$  (7,985,219)	$ 9,326,471

Condensed Consolidating Balance Sheet December 31, 2010
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Assets
Current assets:
Cash and cash equivalents	$    392,525	$           928	$      55,848	$                -	$    449,301
Accounts receivable, net	15,913	135,417	693,969	-	845,299
Other current assets	55,723	165,099	96,183	(6,188)	310,817
Total current assets	464,161	301,444	846,000	(6,188)	1,605,417
Property, plant and equipment, net	179,624	616,114	38,638	-	834,376
Goodwill and intangible assets, net	155,596	5,279,371	463,376	-	5,898,343
Intercompany receivable (payable)	84,107	231,268	(315,375)	-	-
Investment in subsidiaries	6,195,557	-	-	(6,195,557)	-
Other assets	227,822	10,090	48,319	(96,737)	189,494
Total assets	$ 7,306,867	$ 6,438,287	$ 1,080,958	$ (6,298,482)	$ 8,527,630
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued expenses..	$    623,610	$    190,334	$      57,516	$       (6,188)	$    865,272
Current portion of long-term debt	203,659	144,004	1,333	-	348,996
Total current liabilities	827,269	334,338	58,849	(6,188)	1,214,268
Long-term debt	2,295,709	19,342	326,109	-	2,641,160
Other liabilities	150,409	512,681	51,724	(96,737)	618,077
Stockholders' equity:
Quest Diagnostics stockholders' equity...	4,033,480	5,571,926	623,631	(6,195,557)	4,033,480
Noncontrolling interests	-	-	20,645	-	20,645
Total stockholders' equity	4,033,480	5,571,926	644,276	(6,195,557)	4,054,125
Total liabilities and stockholders' equity	$ 7,306,867	$ 6,438,287	$ 1,080,958	$ (6,298,482)	$ 8,527,630

Condensed Consolidating Statement of Cash Flows

Condensed Consolidating Statement of Cash Flows Nine Months Ended September 30, 2011
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Cash flows from operating activities:
Net income	$       281,130	$     258,814	$         52,136	$      (285,322)	$    306,758
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	34,563	162,459	12,409	-	209,431
Provision for doubtful accounts	3,630	41,994	168,749	-	214,373
Provision for special charge	236,000	-	-	-	236,000
Other, net	(291,570)	69,318	(7,869)	285,322	55,201
Changes in operating assets and liabilities	(104,461)	(157,172)	(202,402)	-	(464,035)
Net cash provided by operating activities	159,292	375,413	23,023	-	557,728
Net cash used in investing activities	(1,212,729)	(197,558)	(9,269)	217,498	(1,202,058)
Net cash provided by (used in) financing activities	714,095	(167,869)	(22,874)	(217,498)	305,854
Net change in cash and cash equivalents..	(339,342)	9,986	(9,120)	-	(338,476)
Cash and cash equivalents, beginning of period	392,525	928	55,848	-	449,301
Cash and cash equivalents, end of period.	$        53,183	$      10,914	$       46,728	$                -	$    110,825

Condensed Consolidating Statement of Cash Flows Nine Months Ended September 30, 2010
	Parent	Subsidiary Guarantors	Non- Guarantor Subsidiaries	Eliminations	Consolidated
Cash flows from operating activities:
Net income	$    555,138	$    274,375	$    58,529	$   (305,257)	$    582,785
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	37,183	140,870	12,391	-	190,444
Provision for doubtful accounts	4,171	39,116	179,595	-	222,882
Other, net	(259,463)	15,487	(6,614)	305,257	54,667
Changes in operating assets and liabilities	274,106	(355,766)	(190,660)	-	(272,320)
Net cash provided by operating activities.	611,135	114,082	53,241	-	778,458
Net cash provided by (used in) investing activities	20,930	(106,411)	(3,852)	(50,501)	(139,834)
Net cash used in financing activities	(775,597)	(24,937)	(53,586)	50,501	(803,619)
Net change in cash and cash equivalents..	(143,532)	(17,266)	(4,197)	-	(164,995)
Cash and cash equivalents, beginning of period	464,958	17,457	51,841	-	534,256
Cash and cash equivalents, end of period.	$    321,426	$           191	$    47,644	$                -	$    369,261